ValuentumAd

Official PayPal Seal
Valuentum Reports













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

Feb 19, 2014
Medtronic: A Dividend Growth Gem
Medtronic has market leading products, breadth and scale, and financial strength – all three factors that translate into a strong dividend.
Jan 27, 2014
Surveying Fourth Quarter Earnings at Health Care Firms
Though it may be difficult to focus on underlying equity fundamentals in the face of a volatile overall market environment, we think doing so is even more important under such circumstances. Let’s examine our thoughts on fourth-quarter earnings season in the health care space .
Jan 8, 2014
The Best Ideas for 2014 and Beyond: Part II
Let’s dive into Part II of this special best ideas edition. This article focuses on the positions in the Dividend Growth portfolio.
Nov 19, 2013
Medtronic Posts Better Than Expected Fiscal 2Q Results
Medtronic has been one of the best performers in our Dividend Growth portfolio. Though its yield isn’t as large as that of others, the firm’s dividend growth prospects are fantastic.
Sep 26, 2013
MAKO Receives a Tremendous Offer from Stryker; Is Intuitive Surgical Next?
MAKO receives an offer from Stryker that was an 83% premium to its previous day's closing price. Let’s take a look at the deal and what it may mean for Intuitive Surgical.
Aug 5, 2013
Which Sectors Are Leading the Market Higher? And Why Is This Important?
Identifying sector and industry leadership is very important for the institutional money manager as doing so often leads to undervalued firms that are just starting to have their value recognized by the market — Valuentum stocks. Let’s dig into which sectors have been strong and which ones have been weak so far in 2013.
May 22, 2013
Dividend Growth Gem Medtronic Is a Cash Cow
Full-year free cash flow of $4.4 billion confirms that Medtronic is a cash cow.
Feb 19, 2013
Dividend Growth Portfolio Holding Medtronic Posts Solid Third Quarter
Medtronic’s third quarter was solid. Free cash flow remains terrific.
Jan 22, 2013
Johnson & Johnson’s Long-term Tailwinds Are Intact
Johnson & Johnson reported solid fourth-quarter results. The firm's long-term tailwinds remain intact.
Dec 1, 2012
A Dual Focus on Valuation and Yield Is the Best Way to Combat Changes in Future Dividend Tax Rates
We think a dual focus on both valuation and high-yielders remains the best way to achieve portfolio income growth, while reducing the risk of permanent loss of capital from valuation missteps and exogenous events, namely potential changes in the dividend tax rate.


Latest News and Media
The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.